France· FR:67392245
RENVELA 2,4 g, poudre pour suspension buvable
A medicinal product containing sévélamer (carbonate de), registered in France by SANOFI WINTHROP INDUSTRIE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SÉVÉLAMER (CARBONATE DE)
- Manufacturer
- SANOFI WINTHROP INDUSTRIE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093967079990 sachet(s) copolymère d'éthylène polyester polyéthylène basse densité (PEBD) avec feuille(s) aluminium acide méthacryliqueEUR 126.45
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sévélamer (carbonate de) in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainFOSQUEL 2,4 G POLVO PARA SUSPENSION ORALLaboratorios Rubio S.A.
- ItalyRENVELASANOFI WINTHROP INDUSTRIE
- NetherlandsRenvela 2,4 g, poeder voor orale suspensieSanofi Winthrop Industrie
- PolandRenvelaSanofi Winthrop Industrie
- SwedenSevelamer Ebb 2,4 g Pulver till oral suspensionEbb Medical AB
- United KingdomRenagel 403mg capsulesGenzyme Therapeutics Ltd
- IrelandRenagelSanofi Winthrop Industrie
- SwitzerlandRenagel, comprimés pelliculésSanofi-Aventis (Suisse) SA
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/047a5cf5-8d44-413e-b34b-0d31e2f64e16 GET /v1/drugs/047a5cf5-8d44-413e-b34b-0d31e2f64e16?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67392245",
"date_amm": "2009-06-10",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/09/521",
"substance": "SÉVÉLAMER (CARBONATE DE)",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour suspension buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about sévélamer (carbonate de).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.